ProPublica

Journalism in the Public Interest

Cancel
Health Care

Explore $2 Billion in Drug Company Payments to Physicians

blog comments powered by Disqus

Projects You Can Help With

.

Join Our Reporting Network for Updates on Ways to ‘Get Involved’

Sign Up

5,993 signed up

.

Meet Our New Comments System – Where You Can Share Your Stories, Too

Learn More

.

Discussion: Why Medicare Wastes Billions on Name-Brand Drugs

Join the discussion

.

What’s Your Obamacare Story? Help ProPublica Cover the Affordable Care Act

Share

239 Stories Shared

More on This Investigation

Leaders of Teaching Hospitals Have Close Ties to Drug Companies, Study Shows

Nearly every large drug maker based in the United States had at least one academic medical center official on its board, raising questions about their independence.

Reporting Recipe: Dollars for Docs

With more data on relationships between doctors and drug companies soon to be released, here are some ways journalists can use this information.

Double Dip: Doctors Paid to Advise, Promote Drug Companies That Fund Their Research

Research has been seen as less objectionable than other forms of interactions with drug companies, but 10 percent of researchers have multiple ties among the nine companies ProPublica analyzed. That raises questions about doctors’ impartiality.

Doctor Payments on the Decline

Pharmaceutical company payments to health care professionals dropped between 2011 and 2012 among most of the companies and categories ProPublica tracks, driven in part by increased transparency as well as blockbuster drugs losing patent protection. Research payments, however, have increased among th

As Full Disclosure Nears, Doctors’ Pay for Drug Talks Plummets

As transparency increases and blockbuster drugs lose patent protection, drug companies have dramatically scaled back payments to doctors for promotional talks. This fall, all drug and medical device companies will be required to report payments to doctors.